Thermo Fisher Scientific stock is trading -5.39% below its average target price of $645.46 after marking a 7.5% during today's afternoon session. Analysts are giving the Large-Cap Farm & Heavy Construction Machinery company an average rating of buy and target prices ranging from $585.0 to $767.0 per share.
The stock has a very low short interest at 0.9%, and a short ratio of 1.84. The company's insiders own 0.17% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 90.8% of Thermo Fisher Scientific's shares being owned by this investor type.
Institutions Invested in Thermo Fisher Scientific
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-09-30 | Vanguard Group Inc | 9% | 33,052,711 | $20,185,291,011 |
| 2024-09-30 | Blackrock Inc. | 8% | 29,157,047 | $17,806,208,958 |
| 2024-09-30 | State Street Corporation | 4% | 16,318,961 | $9,965,989,681 |
| 2024-09-30 | Morgan Stanley | 3% | 11,141,548 | $6,804,143,499 |
| 2024-09-30 | Price (T.Rowe) Associates Inc | 3% | 10,973,057 | $6,701,246,043 |
| 2024-09-30 | Capital World Investors | 2% | 9,325,777 | $5,695,252,127 |
| 2024-09-30 | Capital Research Global Investors | 2% | 8,187,683 | $5,000,218,108 |
| 2024-09-30 | FMR, LLC | 2% | 7,877,459 | $4,810,764,307 |
| 2024-09-30 | Geode Capital Management, LLC | 2% | 7,659,943 | $4,677,927,283 |
| 2024-09-30 | JP Morgan Chase & Company | 2% | 6,606,909 | $4,034,839,406 |
Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Thermo Fisher Scientific.
